Delivery Order SPE2DB20D1100-SPE2DB25FZ92S

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,206.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Remicade 100 mg vials, a specialty medication used in the treatment of various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $11,245.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the DLA's Indefinite Delivery Contract (IDC) for medical commodities, with a firm fixed price and an ultimate completion date of January 13, 2025. The contract covers the procurement of REMICADE 100 MG VIALS, a specialty pharmaceutical product, to...
This federal contract award, valued at $1,590.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 mg vials, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance through January 7, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen...
This federal contract award, valued at $19,018.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REMICADE 100 MG VIALS, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $7,469.60, is a Delivery Order for the provision of REMICADE 100 MG VIALS, a prescription medication. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,972.80 firm fixed-price delivery order is for the supply of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $20,995.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remicade 100 mg vials, a specialty medication used in the treatment of various medical conditions. This contract is a delivery order and has a firm fixed price pricing type. The contract has no set-aside designation, indicating open...
This federal contract award is for the supply of REMICADE 100 MG VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the federal government. The contract has a ceiling value of $37,116.58 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Remicade 100 mg vials, a pharmaceutical product. The contract has a ceiling value of $7,470.22 and an ultimate completion date of June 17, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical commodities to the U.S. Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract award, valued at $78,531.28, is for the supply of REMICADE 100MG 20ML 1S, which are pharmaceutical products used in medical treatment. The contract does not have a set-aside designation, indicating open competition. As a major...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ92S
    Delivery Order

This federal contract award, valued at $26,900.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 MG VIALS, a specialty medication, with a completion date of January 7, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

This contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant presence in providing essential medical products and supplies to various federal agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 4/13/25, 12:48 AM